十一月 2025
- Home
- BodyLogicMD
十一月 2025的BodyLogicMD市场份额分析
BodyLogicMD is a network of highly trained bioidentical hormone replacement therapy (BHRT) physicians who specialize in treating hormonal imbalances.
BodyLogicMD(包含公司地区分支机构)
查看更多网站流量和参与度信息- bodylogicmd.com
BodyLogicMD收入截至 十一月 2025为 25M - 50M
BodyLogicMD主要域名产生的收入
3 年中BodyLogicMD主要域名的收入
BodyLogicMD主要域名的收入
BodyLogicMD热门域名的总访问量
了解BodyLogicMD市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
BodyLogicMD热门域名的平均访问时长
分析BodyLogicMD参与度指标。
过去 3 个月的平均访问时长
子公司明细
BodyLogicMD热门域名的平均页面浏览量
了解BodyLogicMD如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
BodyLogicMD 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻BodyLogicMD Franchise Corp. recognized as top 10 Hormone Replacement Therapy provider of 2023.BodyLogicMD named as a top 10 Hormone Replacement Therapy provider of 2023.
十月 18, 2023阅读更多
新闻BodyLogicMD Franchise Corp. launches weight loss, nutrition and wellness programs utilizing telehealth technology and a multidisciplinary approach that encourages sound and sustainable nutrition and wellness principles along with the use of cutting-edge nutraceuticals and pharmaceuticals.BodyLogicMD is rolling out brand new weight loss, nutrition and wellness programs utilizing telehealth technology and a multidisciplinary approach that encourages sound and sustainable nutrition and wellness principles along with the use of cutting-edge nutraceuticals and pharmaceuticals.
九月 9, 2020阅读更多
新闻Myos Corp. partnered with BodyLogicMD Franchise Corp. on May 27th '20.MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS ), a bionutrition company and the owner of Fortetropin ®, a proprietary bioactive composition made from fertilized egg yolk that helps build lean muscle, announced today that it has entered into a distribution agreement with BodyLogicMD, a leading physician-owned network of anti-aging medical practices located throughout the United States.
五月 27, 2020阅读更多
查看 BodyLogicMD 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。